Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Vejle Hospital
National Cancer Institute (NCI)
UNICANCER
IFOM ETS - The AIRC Institute of Molecular Oncology
First Affiliated Hospital of Guangxi Medical University
Pfizer
Charite University, Berlin, Germany
Sun Yat-sen University
Alliance for Clinical Trials in Oncology
Medical University of Vienna
GERCOR - Multidisciplinary Oncology Cooperative Group
University of Roma La Sapienza
Alliance for Clinical Trials in Oncology
Medical Research Council
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Samsung Medical Center
Cancer Research UK, Glasgow
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
UNICANCER
Gruppo Oncologico del Nord-Ovest
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NSABP Foundation Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Southampton
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Sanofi
National Cancer Institute (NCI)
National Cancer Institute (NCI)